AbbVie Inc., and Tentarix Biotherapeutics announced a multi-year collaboration focused on the discovery and development of conditionally-active, multi-specific biologic candidates in oncology and immunology....
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced the clearance, by the U.S. Food and...
New England Biolabs, announced the launch of the NEBNext Enzymatic 5hmC-seq Kit a novel enzyme-based method for the specific detection of 5hmC sites. The gentle,...
AbbVie, announced that it has completed its acquisition of ImmunoGen. With the completion of the acquisition, ImmunoGen is now part of AbbVie.
"Together with ImmunoGen,...
Iambic Therapeutics, a biotechnology company developing novel therapeutics using its AI-driven discovery platform, announced the appointment of oncologist and industry veteran Neil Josephson, M.D.,...
